Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

Drug-induced acute kidney injury: diverse mechanisms of tubular injury.

Perazella MA.

Curr Opin Crit Care. 2019 Sep 2. doi: 10.1097/MCC.0000000000000653. [Epub ahead of print]

PMID:
31483318
2.

Summary of the International Conference on Onco-Nephrology: an emerging field in medicine.

Capasso A, Benigni A, Capitanio U, Danesh FR, Di Marzo V, Gesualdo L, Grandaliano G, Jaimes EA, Malyszko J, Perazella MA, Qian Q, Ronco P, Rosner MH, Trepiccione F, Viggiano D, Zoccali C, Capasso G; International Conference on Onco-Nephrology Participants.

Kidney Int. 2019 Sep;96(3):555-567. doi: 10.1016/j.kint.2019.04.043. Epub 2019 May 31.

PMID:
31445584
3.

Acute kidney injury in the patient with cancer.

Rosner MH, Perazella MA.

Kidney Res Clin Pract. 2019 Sep 30;38(3):295-308. doi: 10.23876/j.krcp.19.042. Review.

4.

The Changing Face of Human Immunodeficiency Virus-Mediated Kidney Disease.

Sury K, Perazella MA.

Adv Chronic Kidney Dis. 2019 May;26(3):185-197. doi: 10.1053/j.ackd.2018.12.001. Review.

PMID:
31202391
5.

Utility of a urine sediment score in hyperbilirubinemia/hyperbilirubinuria
.

Poloni JAT, Perazella MA, Keitel E, Marroni CA, Leite SB, Rotta LN.

Clin Nephrol. 2019 Sep;92(3):141-150. doi: 10.5414/CN109673.

PMID:
31198169
6.

Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis.

Moledina DG, Wilson FP, Pober JS, Perazella MA, Singh N, Luciano RL, Obeid W, Lin H, Kuperman M, Moeckel GW, Kashgarian M, Cantley LG, Parikh CR.

JCI Insight. 2019 May 16;4(10). pii: 127456. doi: 10.1172/jci.insight.127456. eCollection 2019 May 16.

7.

Acute Kidney Injury Related to Sepsis.

Perazella MA.

JAMA. 2019 May 14;321(18):1828. doi: 10.1001/jama.2019.2044. No abstract available.

PMID:
31087016
8.

AKI in Patients Receiving Immune Checkpoint Inhibitors.

Perazella MA, Sprangers B.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1077-1079. doi: 10.2215/CJN.02340219. Epub 2019 May 2. No abstract available.

PMID:
31048326
9.

The nephrotoxicity of new immunotherapies.

Sury K, Perazella MA.

Expert Rev Clin Pharmacol. 2019 Jun;12(6):513-521. doi: 10.1080/17512433.2019.1613888. Epub 2019 May 8. Review.

PMID:
31035801
10.

Cancer Survivorship.

Sprangers B, Jhaveri KD, Perazella MA.

N Engl J Med. 2019 Apr 4;380(14):1381-1382. doi: 10.1056/NEJMc1900709. No abstract available.

PMID:
30943355
11.

Severe Acute Kidney Injury and Double Tubulopathy Due to Dual Toxicity Caused by Combination Antiretroviral Therapy.

Soto K, Campos P, Manso R, Antunes AMM, Morello J, Perazella MA.

Kidney Int Rep. 2018 Nov 28;4(3):494-499. doi: 10.1016/j.ekir.2018.11.014. eCollection 2019 Mar. No abstract available.

12.

Telavancin-associated acute kidney injury
.

Cavanaugh C, Moeckel GW, Perazella MA.

Clin Nephrol. 2019 Mar;91(3):187-191. doi: 10.5414/CN109651.

PMID:
30614441
13.

Pink Urine Syndrome: A Combination of Insulin Resistance and Propofol.

Tucker BM, Perazella MA.

Kidney Int Rep. 2018 Oct 13;4(1):30-39. doi: 10.1016/j.ekir.2018.10.009. eCollection 2019 Jan. Review.

14.

The authors reply.

Perazella MA, Dreicer R, Rosner MH.

Kidney Int. 2018 Dec;94(6):1238-1239. doi: 10.1016/j.kint.2018.08.023. No abstract available.

PMID:
30466568
15.

Treatment of Drug-Induced Acute Tubulointerstitial Nephritis: The Search for Better Evidence.

Moledina DG, Perazella MA.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1785-1787. doi: 10.2215/CJN.12001018. Epub 2018 Nov 5. No abstract available.

PMID:
30397028
16.

Kidney Biopsy-Related Complications in Hospitalized Patients with Acute Kidney Disease.

Moledina DG, Luciano RL, Kukova L, Chan L, Saha A, Nadkarni G, Alfano S, Wilson FP, Perazella MA, Parikh CR.

Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1633-1640. doi: 10.2215/CJN.04910418. Epub 2018 Oct 22.

PMID:
30348813
17.

Urine Sediment Examination in the Diagnosis and Management of Kidney Disease: Core Curriculum 2019.

Cavanaugh C, Perazella MA.

Am J Kidney Dis. 2019 Feb;73(2):258-272. doi: 10.1053/j.ajkd.2018.07.012. Epub 2018 Sep 21. Review.

PMID:
30249419
18.

Acute Kidney Injury in Patients With Cancer.

Perazella MA, Rosner MH.

Oncology (Williston Park). 2018 Jul 15;32(7):351-9.

19.

Cardiorenal complications of immune checkpoint inhibitors.

Sury K, Perazella MA, Shirali AC.

Nat Rev Nephrol. 2018 Sep;14(9):571-588. doi: 10.1038/s41581-018-0035-1. Review.

PMID:
30013100
20.

Opening an onconephrology clinic: recommendations and basic requirements.

Cosmai L, Porta C, Perazella MA, Launay-Vacher V, Rosner MH, Jhaveri KD, Floris M, Pani A, Teuma C, Szczylik CA, Gallieni M.

Nephrol Dial Transplant. 2018 Sep 1;33(9):1503-1510. doi: 10.1093/ndt/gfy188.

21.

Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future.

Perazella MA, Shirali AC.

J Am Soc Nephrol. 2018 Aug;29(8):2039-2052. doi: 10.1681/ASN.2018050488. Epub 2018 Jun 29. Review.

22.

Introduction to Nephropharmacology for the Clinician: A New CJASN Series.

Nolin TD, Perazella MA.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1083-1084. doi: 10.2215/CJN.03180318. Epub 2018 Apr 16. No abstract available.

23.

Renal cell carcinoma for the nephrologist.

Perazella MA, Dreicer R, Rosner MH.

Kidney Int. 2018 Sep;94(3):471-483. doi: 10.1016/j.kint.2018.01.023. Epub 2018 Apr 14. Review.

PMID:
29661544
24.

Pharmacology behind Common Drug Nephrotoxicities.

Perazella MA.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1897-1908. doi: 10.2215/CJN.00150118. Epub 2018 Apr 5.

PMID:
29622670
25.

Blue-green discoloration of urine and false nephrotic range proteinuria at dipstick urinalysis.

Poloni JAT, de Moraes Sassi MG, de Oliveira TF, Rotta LN, Perazella MA.

Clin Chim Acta. 2018 Jul;482:74-77. doi: 10.1016/j.cca.2018.03.036. Epub 2018 Mar 31.

PMID:
29608875
26.

Adverse Events Associated with Immune Checkpoint Blockade.

Jhaveri KD, Perazella MA.

N Engl J Med. 2018 Mar 22;378(12):1163. doi: 10.1056/NEJMc1801663. No abstract available.

PMID:
29565518
27.

Update on the nephrotoxicity of novel anticancer agents
.

Nussbaum EZ, Perazella MA.

Clin Nephrol. 2018 Mar;89(3):149-165. doi: 10.5414/CN109371. Review.

PMID:
29350175
28.

Anticancer Drug-Induced Acute Kidney Injury.

Izzedine H, Perazella MA.

Kidney Int Rep. 2017 Feb 16;2(4):504-514. doi: 10.1016/j.ekir.2017.02.008. eCollection 2017 Jul. Review.

29.

Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease.

Ermer T, Kopp C, Asplin JR, Granja I, Perazella MA, Reichel M, Nolin TD, Eckardt KU, Aronson PS, Finkelstein FO, Knauf F.

Kidney Int Rep. 2017 Jun 8;2(6):1050-1058. doi: 10.1016/j.ekir.2017.06.002. eCollection 2017 Nov.

30.

Atypical case of classical polyarteritis nodosa: alveolar hemorrhage and positive antineutrophil cytoplasmic antibody
.

Sitkin NA, Bernstein E, Perazella MA.

Clin Nephrol. 2018 Jan;89 (2018)(1):61-66. doi: 10.5414/CN109156.

PMID:
29162217
31.

Acute kidney injury and electrolyte disorders in the critically ill patient with cancer.

Rosner MH, Capasso G, Perazella MA.

Curr Opin Crit Care. 2017 Dec;23(6):475-483. doi: 10.1097/MCC.0000000000000450. Review.

PMID:
28953555
32.

Drug-Induced Acute Interstitial Nephritis.

Moledina DG, Perazella MA.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2046-2049. doi: 10.2215/CJN.07630717. Epub 2017 Sep 11. Review. No abstract available.

33.

Acute Kidney Injury in Patients with Cancer.

Rosner MH, Perazella MA.

N Engl J Med. 2017 Aug 3;377(5):500-501. doi: 10.1056/NEJMc1707248. No abstract available.

PMID:
28767352
34.

Harnessing basic and clinic tools to evaluate SGLT2 inhibitor nephrotoxicity.

Saly DL, Perazella MA.

Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F951-F954. doi: 10.1152/ajprenal.00250.2017. Epub 2017 Jun 21.

35.

The Role of PET Scanning in the Evaluation of Patients With Kidney Disease.

Krishnan N, Perazella MA.

Adv Chronic Kidney Dis. 2017 May;24(3):154-161. doi: 10.1053/j.ackd.2017.01.002. Review.

PMID:
28501078
36.

Acute Kidney Injury in Patients with Cancer.

Rosner MH, Perazella MA.

N Engl J Med. 2017 May 4;376(18):1770-1781. doi: 10.1056/NEJMra1613984. Review. No abstract available.

PMID:
28467867
37.

Diagnostic Testing in AKI: Let's Move the Field Forward.

Perazella MA.

J Hosp Med. 2017 May;12(5):380-381. doi: 10.12788/jhm.2735. No abstract available.

PMID:
28459911
38.

Kidney Injury and Repair Biomarkers in Marathon Runners.

Mansour SG, Verma G, Pata RW, Martin TG, Perazella MA, Parikh CR.

Am J Kidney Dis. 2017 Aug;70(2):252-261. doi: 10.1053/j.ajkd.2017.01.045. Epub 2017 Mar 28. Erratum in: Am J Kidney Dis. 2017 Sep;70(3):452.

39.

Adverse kidney effects of epidermal growth factor receptor inhibitors.

Izzedine H, Perazella MA.

Nephrol Dial Transplant. 2017 Jul 1;32(7):1089-1097. doi: 10.1093/ndt/gfw467. Review.

PMID:
28339780
40.

A Rarely Recognized Cause of Acute Kidney Injury in Rhabdomyolysis.

Tesser Poloni JA, Perazella MA.

Am J Med Sci. 2018 Sep;356(3):e27. doi: 10.1016/j.amjms.2017.03.028. Epub 2017 Mar 22. No abstract available.

PMID:
30049408
41.

Clinical Approach to Diagnosing Acute and Chronic Tubulointerstitial Disease.

Perazella MA.

Adv Chronic Kidney Dis. 2017 Mar;24(2):57-63. doi: 10.1053/j.ackd.2016.08.003. Review.

PMID:
28284380
42.

Paraprotein-Related Kidney Disease: Attack of the Killer M Proteins.

Perazella MA, Finkel KW; American Society of Nephrology Onco-Nephology Forum.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2256-2259.

43.

Checkmate: kidney injury associated with targeted cancer immunotherapy.

Perazella MA.

Kidney Int. 2016 Sep;90(3):474-6. doi: 10.1016/j.kint.2016.05.024.

PMID:
27521108
44.

The renal effects of ALK inhibitors.

Izzedine H, El-Fekih RK, Perazella MA.

Invest New Drugs. 2016 Oct;34(5):643-9. doi: 10.1007/s10637-016-0379-y. Epub 2016 Jul 29. Review.

PMID:
27468827
45.

Cancer and Mortality in Solid-Organ Transplantation: Preventable or Inevitable?

Asch WS, Perazella MA.

Am J Kidney Dis. 2016 Dec;68(6):839-842. doi: 10.1053/j.ajkd.2016.06.009. Epub 2016 Jul 9. No abstract available.

PMID:
27405594
46.

Acute kidney injury: Preventing acute kidney injury through nephrotoxin management.

Perazella MA, Wilson FP.

Nat Rev Nephrol. 2016 Sep;12(9):511-2. doi: 10.1038/nrneph.2016.95. Epub 2016 Jul 4. No abstract available.

PMID:
27374917
47.

Phosphate enemas and GFR decline: it's premature to sound the alarm.

Markowitz GS, Bomback AS, Perazella MA.

Kidney Int. 2016 Jul;90(1):13-5. doi: 10.1016/j.kint.2016.05.006.

PMID:
27312439
48.

Harmonization of Renal Function Assessment Is Needed Throughout the Whole Process of Anticancer Drug Development.

Porta C, Cosmai L, Gallieni M, Perazella MA.

J Clin Oncol. 2016 Jul 10;34(20):2429-30. doi: 10.1200/JCO.2016.67.0786. Epub 2016 May 16. No abstract available.

PMID:
27185852
49.

Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients.

Shirali AC, Perazella MA, Gettinger S.

Am J Kidney Dis. 2016 Aug;68(2):287-291. doi: 10.1053/j.ajkd.2016.02.057. Epub 2016 Apr 22.

PMID:
27113507
50.

American Society of Nephrology Quiz and Questionnaire 2015: ESRD/RRT.

Lok CE, Perazella MA, Choi MJ.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1313-20. doi: 10.2215/CJN.01280216. Epub 2016 Apr 19.

Supplemental Content

Loading ...
Support Center